Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Herpes Zoster

Treatments: Other: Data collection

Study type: Observational

Funder types: Industry

Identifiers

NCT01521286

114617

Details and patient eligibility

About

The purpose of this study is to collect data on the incidence, complications and impact on quality of life of herpes zoster (HZ) disease in adults >=50 years of age in Spain. This study will also collect data on costs related to the HZ disease, especially postherpetic neuralgia (PHN)

Enrollment: 552 patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• A male or female >=50 years of age at the time of study enrolment presenting with acute HZ;

• HZ diagnosis for this HZ episode;

  • is the subject's first outpatient diagnosis; OR
  • took place at another site/ centre up to seven days before the initial visit for the present study;

• Ability to comply with study procedures*;

• Written informed consent obtained from the subject*. Note: * will be applicable to secondary objectives only and not for the primary objective to calculate incidence.

Exclusion criteria

• Subject participating in another research study. Note: This exclusion criteria is applicable to secondary objectives only and not for the primary objectives to calculate incidence.

Trial design

552 participants in 1 patient group

Group A

Description:

Subjects presenting with HZ episode.

Treatment:

Other: Data collection